HER2 membrane proteins play a special role in certain types of breast cancer: amplified levels of HER2 drive unrestricted cell growth. HER2-tailored antibody-based therapeutics aim to prevent cancer cell growth. However, two-thirds of HER2 positive breast cancer patients develop resistance...
The third of a three-part series in which ASHP Foundation Oncology trainees share their experiences Dear ASHP Members, Glenn Williams is the third and final ASHP Foundation Oncology Trainee in our series to share his experiences in the program. Glenn isn't on ASHP Connect, so I'm using my...
The second of a three-part series in which ASHP Foundation Oncology trainees share their experiences My name is Carolyn O’Donnell R.Ph. BCOP, and I work as a clinical oncology application analyst at Lancaster General Health (LGHealth) in Lancaster, Pennsylvania. I completed the ASHP...
The first of a three-part series in which ASHP Foundation Oncology trainees share their experiences. I got the confirmation: I had been chosen for the 2012 ASHP Foundation Oncology Traineeship and to go to The Johns Hopkins Hospital. Johns Hopkins! I was thrilled for the opportunity to...